» Articles » PMID: 18187931

Microarray Analysis of Glomerular Gene Expression in Murine Lupus Nephritis

Overview
Journal J Pharmacol Sci
Specialty Pharmacology
Date 2008 Jan 12
PMID 18187931
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

To elucidate the molecular mechanism of glomerular events in lupus nephritis, we performed genome-wide mRNA expression analysis of glomeruli microdissected from lupus mice. MRL/lpr mice (12-week-old) were orally given vehicle or prednisolone (10 mg/kg per day) for 4 weeks. Renal histology of MRL/lpr mice revealed mesangial proliferative glomerulonephritis with cellular infiltration of macrophages, T cells, and neutrophils. We identified 567 up-regulated genes in MRL/lpr glomeruli compared to control congenic mice. Those included complement components, adhesion molecules, chemokines and their receptors, and molecules related to antigen presentation. Over 130 genes were considered preferentially or exclusively expressed in hematopoietic cell lineages possibly reflecting leukocytes accumulation. Of note is the finding that chemokines and chemokine receptors (CCL3, CCL4, CCL5, CXCL9, CXCL10, CXCL11, CXCL16, CCR5, CXCR3, and CXCR6) that are related to T helper 1 (Th1) cells accumulation were up-regulated concomitantly with increased expression of Ebi3, a subunit of IL-27 that plays a role in Th1 predominance. These changes were accompanied by increased mRNA expression of many genes that were inducible by Th1 cytokine interferon-gamma. Prednisolone markedly attenuated glomerular lesion and leukocyte influx parallel with the reduction of enhanced gene expression. The present study shows additional evidence supporting glomerular Th1 cells accumulation and their role. Our data also provide an important resource in seeking new therapeutic targets to lupus nephritis. Supplemental table: available only at http://dx.doi.org/10.1254/jphs.FP0071337.

Citing Articles

Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis.

Tsai C, Li K, Shen C, Lu C, Lee H, Wu T Int J Mol Sci. 2023; 24(12).

PMID: 37373215 PMC: 10298725. DOI: 10.3390/ijms241210066.


Comparative effects of human-equivalent low, moderate, and high dose oral prednisone intake on autoimmunity and glucocorticoid-related toxicity in a murine model of environmental-triggered lupus.

Heine L, Benninghoff A, Ross E, Rajasinghe L, Wagner J, Lewandowski R Front Immunol. 2022; 13:972108.

PMID: 36341330 PMC: 9627297. DOI: 10.3389/fimmu.2022.972108.


Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.

Soliman S, Haque A, Vanarsa K, Zhang T, Ismail F, Lee K Front Immunol. 2022; 13:885307.

PMID: 35720325 PMC: 9204340. DOI: 10.3389/fimmu.2022.885307.


CXCL16/ERK1/2 pathway regulates human podocytes growth, migration, apoptosis and epithelial mesenchymal transition.

Chen Y, Wang Z, Li Q, Tian M, Zhu Y, Yu L Mol Med Rep. 2022; 25(6).

PMID: 35514316 PMC: 9133949. DOI: 10.3892/mmr.2022.12728.


Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL. mice.

Lee H, Kim H, Pyo M, Park E, Jang S, Won Jun H Theranostics. 2020; 10(22):10186-10199.

PMID: 32929342 PMC: 7481409. DOI: 10.7150/thno.46835.